Opinions & Features

Challenging Obamacare is sure to be one of the top priorities of the newly convened 2015 Congress.

Making predictions for the New Year may feel as productive as peering into a crystal ball. But in the life sciences, hard science and long experience back prognostication.

A real healthcare crisis has been in the works for the last half-century and it has nothing to do with the cost of healthcare, although you could argue it has something to do with the[...]

With White Knight Actavis standing in its corner, Allergan was able to outmaneuver Valeant Pharmaceuticals and Bill Ackman’s hedge fund, Pershing Square Capital, breaking a seven-month siege of the company.

The Allergan saga just became the stuff of George R.R. Martin novels.

Over the last 12 months, failures in the VA healthcare system have dominated reporting about the Veterans Administration.

This has been an attention-grabbing week for Ebola in America.

Ebola has evoked our worst nightmares as it continues to outrun containment efforts.

Have you ever wondered how our society values innovation, how it rewards breakthrough discoveries? Most people say that it’s the price we place on new drugs that show how much we value the breakthrough.[...]

Steve Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system, which he believes will be unsustainable without therapies that work more[...]